tiprankstipranks
Trending News
More News >
Biogen Inc. (BIIB)
:BIIB
US Market
Advertisement

Biogen (BIIB) Technical Analysis

Compare
4,911 Followers

Technical Sentiment

Overall Consensus
Buy
12Bullish
6Neutral
4Bearish
Technical Analysis Consensus
Buy
4Bullish
6Neutral
0Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Biogen Inc.’s (BIIB) Moving Averages Convergence Divergence (MACD) indicator is 2.67, suggesting Biogen Inc. is a Buy.
Biogen Inc.’s (BIIB) 20-Day exponential moving average is 141.16, while Biogen Inc.’s (BIIB) share price is $142.5, making it a Buy.
Biogen Inc.’s (BIIB) 50-Day exponential moving average is 136.92, while Biogen Inc.’s (BIIB) share price is $142.5, making it a Buy.

Biogen (BIIB) Pivot Points

Sep 20, 2025, 11:23 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
139.56
141.46
142.64
144.54
145.72
147.62
148.80
Fibonacci
141.46
142.64
143.37
144.54
145.72
146.45
147.62
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Biogen (BIIB) Moving Averages

Sep 20, 2025, 11:23 AM
Period
Simple
Exponential
MA5
143.64Sell
143.55Sell
MA10
143.94Sell
143.09Sell
MA20
140.75Buy
141.16Buy
MA50
135.05Buy
136.92Buy
MA100
131.27Buy
135.52Buy
MA200
136.04Buy
142.45Buy
Biogen Inc.’s (BIIB) 10-Day exponential moving average is 143.09, while Biogen Inc.’s (BIIB) share price is $142.5, making it a Sell.
Biogen Inc.’s (BIIB) 100-Day exponential moving average is 135.52, while Biogen Inc.’s (BIIB) share price is $142.5, making it a Buy.
Biogen Inc.’s (BIIB) stock price is $142.5 and Biogen Inc.’s (BIIB) 50-day simple moving average is 135.05, creating a Buy signal.
Biogen Inc.’s (BIIB) stock price is $142.5 and Biogen Inc.’s (BIIB) 100-day simple moving average is 131.27, creating a Buy signal.
Biogen Inc.’s (BIIB) stock price is $142.5 and Biogen Inc.’s (BIIB) 200-day simple moving average is 136.04, creating a Buy signal.

Biogen (BIIB) Technical Indicators

Sep 20, 2025, 11:23 AM
Name
Value
Implied Action
RSI (14)
55.14
Neutral
STOCH (9,6)
45.59
Neutral
STOCHRSI (14)
63.41
Neutral
MACD (12,26)
2.67
Buy
ADX (14)
22.23
Neutral
Williams %R
-46.45
Buy
CCI (14)
39.56
Neutral
ATR (14)
4.17
-
Ultimate Oscillator
45.20
Neutral
ROC
7.77
Buy
Biogen Inc.’s (BIIB) Relative Strength Index (RSI) is 55.14, creating a Neutral signal.
Biogen Inc.’s (BIIB) Trend Strength Indicator (ADX) is 22.23, creating a Neutral signal.
Biogen Inc.’s (BIIB) Commodity Channel Index (CCI) is 39.56, creating a Neutral signal.
Biogen Inc.’s (BIIB) Price Rate of Change (ROC) is 7.77, creating a Buy signal.

FAQ

Is BIIB a Buy, Hold, or Sell?
Based on BIIB’s technical indicators, BIIB is a Buy.
    What is BIIB’s RSI (14)?
    BIIB’s RSI (14) is 55.14, which suggests BIIB is a Neutral.
      What is BIIB’s MACD?
      BIIB’s MACD is 2.67, which suggests BIIB is a Buy.
        What is BIIB’s 5-day moving average?
        BIIB’s 5-day moving average is 143.64, which suggests BIIB is a Sell.
          What is BIIB’s 20-day moving average?
          BIIB 20-day moving average is 140.75, which suggests BIIB is a Buy.
            What is BIIB’s 50-day moving average?
            BIIB’s 50-day moving average is 135.05, which suggests BIIB is a Buy.
              What is BIIB’s 200-day moving average?
              BIIB’s 200-day moving average is 136.04, which suggests BIIB is a Buy.
                What is BIIB’s Williams % R (14)?
                BIIB’s Williams % R (14) is -46.45, which suggests BIIB is a Buy.
                  What is BIIB’s CCI (14)?
                  BIIB’s CCI (14) is 39.56, which suggests BIIB is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis